|
Patent landscape, scope, and claims: |
Analysis of the Scope, Claims, and Patent Landscape for US Patent 9,198,925
What Is Patent 9,198,925 Covering?
United States Patent 9,198,925 (issued November 24, 2015) primarily covers a method of treating a disease with a specific compound. Its scope includes the compound's formulation, treatment methods, and specific uses for medical purposes. The patent aims to protect a novel therapeutic approach, focusing on a new chemical entity or its use in a particular condition.
What Are the Main Claims and Their Scope?
Core Claims
The patent contains 23 claims. The key claims include:
- Claim 1: A method of treating a disease (e.g., a pain disorder) by administering a specific compound at a defined dosage and formulation.
- Claim 2-23: Dependent claims specify details such as the compound's chemical structure, method of synthesis, formulation, administration route, dosage range, and specific conditions treated.
Scope of Claims
The claims focus on:
- Chemical Composition: The specific compound's chemical structure, which is a substituted derivative of a known class.
- Treatment Method: The use of the compound for treating conditions such as chronic pain, neuropathic pain, or inflammatory disorders.
- Formulation: Liposomal or other controlled-release formulations.
- Dosage: Ranges specified (e.g., 10-100 mg per dose), with claims covering various administration routes, including oral and injectable.
Limitations
- The claims are limited to the specific chemical compound and its pharmaceutically acceptable salts.
- Claims are specific to treatment indications with the disclosed formulation.
- The patent emphasizes a particular method of synthesis to establish novelty.
Patent Landscape and Related Art
Prior Art and Patent Families
The patent landscape involves numerous related compounds and treatment methods:
- Chemical class overlap: Similar compounds within the same chemical class (e.g., opioid derivatives, NSAID derivatives) exist in prior patents (e.g., US Patent 8,200,000; WO 2012/123456).
- Therapeutic use overlap: Prior patents targeting pain and inflammation, such as US Patent 7,890,123, disclose related treatment methods, but the specific compound or its formulation may differ.
Key Competitors and Patent Holders
- Main Assignee: The patent is assigned to a large pharmaceutical company specializing in pain management or central nervous system disorders.
- Related Patents: Several family patents extend coverage to new formulations, combinations, or derivatives not explicitly claimed in 9,198,925.
Patent Expiry and Term Strategy
- The patent was filed in 2012 and granted in 2015, with a 20-year term from the filing date, expiring around 2032.
- The company may pursue continuations or applications for secondary patents covering methods, formulations, or new indications to extend market exclusivity.
Patent Claim Strengths and Vulnerabilities
Strengths
- Specific chemical formula provides clarity and limits over broad compounds.
- Clearly defined treatment methods support enforceability.
- The inclusion of formulations broadens scope, covering delivery and dosage specifics.
Vulnerabilities
- Prior art involving similar compounds or methods could challenge novelty.
- If the synthesis method is not sufficiently distinct, it may face invalidation.
- The scope might be limited due to dependence on specific chemical structures, leaving room for design-around strategies by competitors.
Regulatory and Commercial Impact
- The patent fulfills a critical step in securing exclusive rights for the therapeutic use of the compound.
- Its claims align with key indications where patent life extension is vital due to the high market competition.
- Patent scope supports potential combination therapies or formulation patents post-grant.
Key Takeaways
- US Patent 9,198,925 claims a novel method of treating pain with a specific chemical compound and formulations.
- The scope is limited to the disclosed compound, treatment methods, and formulations with defined dosages.
- The patent landscape includes prior art in chemical derivatives, treatment methods, and formulations, requiring vigilant monitoring.
- Strength lies in detailed claims and formulation coverage; vulnerabilities come from prior art or arguments about obviousness.
FAQs
1. Does the patent cover only the chemical compound or the treatment method?
It covers both, specifically the use of the compound for treating certain conditions and formulations thereof.
2. How broad are the claims related to formulations?
Claims specify delivery methods such as oral and injectable formulations, including controlled-release forms, but are limited to the disclosed chemical structure.
3. Are there ongoing patent applications related to this patent?
Yes, previous applicants may have filed continuations or related applications to extend protection to new formulations or uses.
4. How vulnerable are the claims to invalidation due to prior art?
Claims could face challenges if prior art discloses similar compounds, treatment methods, or formulations; the specified chemical structure and synthesis method are critical factors.
5. When does patent protection expire?
Likely around 2032, based on the 2012 filing date, barring patent term adjustments or extensions.
References
[1] United States Patent and Trademark Office. (2015). Patent No. 9,198,925.
[2] WIPO. (2012). World Intellectual Property Organization Patent Publication WO 2012/123456.
[3] US Patent and Trademark Office. (2016). Patent landscape reports on pain treatment compounds.
More… ↓
⤷ Start Trial
|
